Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 4,227 | 2,057 | 3,375 | 5,090 | 4,129 |
| Cost of Goods | 1,678 | 1,238 | 1,569 | 2,376 | 1,920 |
| Gross Profit | 2,549 | 819 | 1,806 | 2,714 | 2,209 |
| Operating Expenses | 4,629 | 5,032 | 5,815 | 5,320 | 5,768 |
| Operating Income | -1,402 | -3,975 | -3,440 | -2,230 | -2,639 |
| Interest Expense | 18 | 65 | 72 | 59 | 79 |
| Other Income | -1 | 1,331 | 621 | -1,124 | 646 |
| Pre-tax Income | -1,421 | -2,709 | -2,891 | -3,413 | -2,072 |
| Net Income Continuous | -1,421 | -2,709 | -2,891 | -3,413 | -2,072 |
| Net Income | $-1,421 | $-2,709 | $-2,891 | $-3,413 | $-2,072 |
| EPS Basic Total Ops | -0.54 | -1.24 | -1.80 | -1.88 | -1.53 |
| EPS Basic Continuous Ops | -0.54 | -1.24 | -1.71 | -1.96 | -1.53 |
| EPS Diluted Total Ops | -0.54 | -1.24 | -1.80 | -1.88 | -1.53 |
| EPS Diluted Continuous Ops | -0.54 | -1.24 | -1.71 | -1.96 | -1.53 |
| EPS Diluted Before Non-Recurring Items | -0.54 | -1.24 | -1.80 | -2.10 | -1.50 |
| EBITDA(a) | $-1,035 | $-3,598 | $-3,062 | $-1,832 | $-2,232 |